Follow
Łukasz Michał Szafron
Łukasz Michał Szafron
Centrum Onkologii-Instytut
Verified email at coi.waw.pl
Title
Cited by
Cited by
Year
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ...
Nature genetics 49 (5), 680-691, 2017
3962017
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study
JS Ong, G Cuellar-Partida, Y Lu, Australian Ovarian Cancer Study, ...
International journal of epidemiology 45 (5), 1619-1630, 2016
1382016
Ovarian small cell carcinoma of hypercalcemic type–evidence of germline origin and smarca4 gene inactivation. A pilot study
J Kupryjańczyk, A Dansonka-Mieszkowska, J Moes-Sosnowska, ...
Polish Journal of Pathology 64 (4), 238-246, 2013
1092013
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer
Y Lu, G Cuellar-Partida, JN Painter, DR Nyholt, ...
Human molecular genetics 24 (20), 5955-5964, 2015
712015
Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection
M Sromek, M Glogowski, M Chechlinska, M Kulinczak, L Szafron, ...
Cellular Oncology 40, 529-536, 2017
632017
Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10
B Charbonneau, MS Block, WR Bamlet, RA Vierkant, KR Kalli, Z Fogarty, ...
Cancer research 74 (3), 852-861, 2014
612014
The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients
LM Szafron, A Balcerak, EA Grzybowska, B Pienkowska-Grela, ...
Oncotarget 6 (41), 43897, 2015
552015
The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues
LM Szafron, A Balcerak, EA Grzybowska, B Pienkowska-Grela, ...
PloS one 10 (5), e0127475, 2015
522015
Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk
Y Yang, L Wu, X Shu, Y Lu, XO Shu, Q Cai, A Beeghly-Fadiel, B Li, F Ye, ...
Cancer research 79 (3), 505-517, 2019
472019
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA
MA Earp, LE Kelemen, AM Magliocco, KD Swenerton, G Chenevix-Trench, ...
Human genetics 133, 481-497, 2014
332014
Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type
J Moes-Sosnowska, L Szafron, D Nowakowska, ...
Orphanet journal of rare diseases 10, 1-6, 2015
322015
Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
A Felisiak-Golabek, A Rembiszewska, IK Rzepecka, L Szafron, R Madry, ...
Journal of ovarian research 4, 1-9, 2011
272011
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes
G Cuellar-Partida, Y Lu, SC Dixon, Australian Ovarian Cancer Study, ...
Human genetics 135, 741-756, 2016
262016
High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations
IK Rzepecka, L Szafron, A Stys, M Bujko, J Plisiecka-Halasa, R Madry, ...
Cancer genetics 205 (3), 94-100, 2012
262012
Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas
J Moes-Sosnowska, IK Rzepecka, J Chodzynska, ...
Cancer biology & therapy 20 (6), 843-854, 2019
252019
Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers
DM Glubb, DJ Thompson, KKH Aben, A Alsulimani, F Amant, D Annibali, ...
Cancer Epidemiology, Biomarkers & Prevention 30 (1), 217-228, 2021
172021
Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study
JS Ong, LD Hwang, G Cuellar-Partida, NG Martin, G Chenevix-Trench, ...
International journal of epidemiology 47 (2), 450-459, 2018
172018
p19INK4d mRNA and protein expression as new prognostic factors in ovarian cancer patients
A Felisiak-Golabek, A Dansonka-Mieszkowska, IK Rzepecka, L Szafron, ...
Cancer biology & therapy 14 (10), 973-981, 2013
152013
The significance of c. 690G> T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome
B Konopka, LM Szafron, E Kwiatkowska, A Podgorska, A Zolocinska, ...
Oncotarget 7 (41), 67412, 2016
142016
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer
SP Kar, DPC Considine, JP Tyrer, JT Plummer, S Chen, FS Dezem, ...
Human Genetics and Genomics Advances 2 (3), 2021
122021
The system can't perform the operation now. Try again later.
Articles 1–20